<p>The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.</p>

Subscribe

Title Date published
An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D. 2024-09-23
Picking Biotech Jockeys With SR One's Simeon George, M.D. 2024-09-16
Embracing Biotech Chaos With Memo's Erik van den Berg 2024-09-09
Pivoting To RNA With Circio's Dr. Erik Digman Wiklund 2024-09-02
mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D. 2024-08-26
Steering Through Setbacks with AVEO Oncology's Michael Bailey 2024-08-19
Leading From Within with ISCT & Kiji's Miguel Forte, M.D. 2024-08-12
The Allogeneic Future with Poseida's Kristin Yarema, Ph.D. 2024-08-05
Expanding The Proteome with ProFound's John Lepore, M.D. 2024-07-29
From The Bench To The Boardroom with ImmunityBio's Enrique Diloné 2024-07-22
First AI Antibody In Humans with Aulos' Aron Knickerbocker 2024-07-15
Drug Delivery Differentiators with Syncromune's Eamonn Hobbs 2024-07-08
Topical Ocular Biologics with Claris Bio's Clarke Atwell 2024-07-01
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley 2024-06-24
True DEI Value in Biopharma with Arcellx's Rami Elghandour 2024-06-17
Mission-Driven Dementia Funding with DDF's Jonathan Behr 2024-06-10
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller 2024-06-03
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D. 2024-05-27
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch 2024-05-20
A New Prescription For PBMs with Allan Shaw 2024-05-13
1234567891011121314

Comments about Business Of Biotech

comments powered by Disqus
Advertisment: